Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
NCT00803816
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Uveitis
Interventions
DRUG:
everolimus
Sponsor
Carsten Heinz